Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction

被引:45
|
作者
Farwell, WR
Sesso, HD [1 ]
Buring, JE
Gaziano, JM
机构
[1] Brigham & Womens Hosp, Vet Affairs Med Ctr, Dept Med, Div Aging, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Vet Affairs Med Ctr, Dept Med, Div Prevent Med, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Vet Affairs Med Ctr, Dept Med, Div Cardiovasc, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
[5] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Dept Ambulatorio Care & Prevent, Boston, MA 02115 USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2005年 / 96卷 / 08期
关键词
D O I
10.1016/j.amjcard.2005.06.044
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Low-density lipoprotein (LDL) cholesterol is the primary lipid parameter targeted to prevent myocardial infarction. Alternatively, non-high-density lipoprotein (HDL) cholesterol includes LDL cholesterol and other atherogenic particles but does not require a fasting sample. Non-HDL cholesterol and LDL cholesterol as predictors of first nonfatal myocardial infarction were compared in 303 patients and 297 controls matched for age, gender, and community within the Boston Area Health Study. Patients were white men or women aged <76 years living in the Boston area, without a history of myocardial infarction or angina pectoris, in whom symptoms of confirmed myocardial infarction began during the 24 hours before admission. After multivariate adjustment for coronary risk factors in unmatched analyses, the corresponding odds ratios (ORs) of a first nonfatal myocardial infarction for non-HDL cholesterol in the second, third, and fourth quartiles were 1.83 (95% confidence interval [CI] 1.07 to 3.14), 2.07 (95% CI 1.23 to 3.49), and 2.33 (95% CI 1.39 to 3.90) (p trend <0.01). For LDL cholesterol, the ORs were 1.10 (95% CI 0.67 to 1.81), 0.87 (95% CI 0.52 to 1.46), and 1.45 (95% CI 0.90 to 2.35) (p trend = 0.16). Including HDL cholesterol in the model increased the ORs and strengthened the test for a trend for LDL cholesterol, whereas the ORs were decreased and the test for a trend was weakened for non-HDL cholesterol. In conclusion, given that non-HDL cholesterol accounts for LDL cholesterol plus other atherogenic particles but does not require a fasting sample, this study suggests that non-HDL cholesterol may be at least as useful as LDL cholesterol to initially screen patients for risk of a first nonfatal myocardial infarction. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1129 / 1134
页数:6
相关论文
共 50 条
  • [41] Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol
    Liliana Fonseca
    Sílvia Paredes
    Helena Ramos
    José Carlos Oliveira
    Isabel Palma
    Lipids in Health and Disease, 19
  • [42] Relationship between Non-High-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol in the General Population: the KOBE Study and Tsuruoka Metabolomic Cohort Study
    Kuwabara, Kazuyo
    Harada, Sei
    Sugiyama, Daisuke
    Kurihara, Ayako
    Kubota, Yoshimi
    Higashiyama, Aya
    Hirata, Takumi
    Nishida, Yoko
    Kawasaki, Midori
    Takebayashi, Toru
    Okamura, Tomonori
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2016, 23 (04) : 477 - 490
  • [43] Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol
    Fonseca, Liliana
    Paredes, Silvia
    Ramos, Helena
    Oliveira, Jose Carlos
    Palma, Isabel
    LIPIDS IN HEALTH AND DISEASE, 2020, 19 (01)
  • [44] Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol
    deGoma, Emil M.
    Leeper, Nicholas J.
    Heidenreich, Paul A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (01) : 49 - 55
  • [45] Low-density lipoprotein cholesterol paradox in patients with acute myocardial infarction
    Lee, J. H.
    Chae, S. C.
    Jeong, M. H.
    Kim, Y. J.
    Kim, K. S.
    Hur, S. H.
    Seong, I. W.
    Hong, T. J.
    Cho, M. C.
    Kim, C. J.
    EUROPEAN HEART JOURNAL, 2009, 30 : 34 - 35
  • [46] The relationship between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and hyperuricaemia
    Wang, Zhaoxiang
    Wu, Menghuan
    Du, Ruiqin
    Tang, Fengyan
    Xu, Mengjiao
    Gu, Tian
    Yang, Qichao
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [47] Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
    Katsiki, Niki
    Vrablik, Michal
    Banach, Maciej
    Gouni-Berthold, Ioanna
    PHARMACEUTICALS, 2023, 16 (04)
  • [48] Low-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio is a Useful Risk Marker for Acute Myocardial Infarction and Sudden Death in Normocholesterolemic Male Population
    Tanaka, Fumitaka
    Makita, Shinji
    Onoda, Toshiyuki
    Itai, Kazuyoshi
    Ohsawa, Masaki
    Tanno, Kozo
    Sakata, Kiyomi
    Kawamura, Kazuko
    Okayama, Akira
    Nakamura, Motoyuki
    CIRCULATION, 2011, 124 (21)
  • [49] Low-density lipoprotein cholesterol cannot be too low after a myocardial infarction
    Wulff, Anders B.
    Mortensen, Martin B.
    Nordestgaard, Borge G.
    JOURNAL OF INTERNAL MEDICINE, 2023, 294 (05) : 540 - 542
  • [50] Apolipoprotein B and Non-High-Density Lipoprotein Cholesterol Are Better Risk Markers for Coronary Artery Disease than Low-Density Lipoprotein Cholesterol in Hypertriglyceridemic Metabolic Syndrome Patients
    Boumaiza, Imen
    Omezzine, Asma
    Rejeb, Jihene
    Rebhi, Lamia
    Kalboussi, Nesrine
    Ben Rejeb, Nabila
    Nabli, Naoufel
    Ben Abdelaziz, Ahmed
    Boughazala, Essia
    Bouslama, Ali
    METABOLIC SYNDROME AND RELATED DISORDERS, 2010, 8 (06) : 515 - 522